Celltrion Gets Ready For Denosumab Phase III

Study For Prolia Rival Follows Ustekinumab Phase III Trial

 
• By Dave Wallace

Celltrion has kicked off plans for a Phase III trial for its denosumab biosimilar rival to Prolia.

Clinical_Trial_Puzzle
Celltrion is getting ready to begin Phase III trials for denosumab • Source: Shutterstock

More from Biosimilars

More from Products